nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ATP4A—esophageal cancer	0.605	1	CbGaD
Rabeprazole—ABCG2—Carboplatin—esophageal cancer	0.052	0.298	CbGbCtD
Rabeprazole—ABCG2—Cisplatin—esophageal cancer	0.0444	0.255	CbGbCtD
Rabeprazole—CYP2C9—Capecitabine—esophageal cancer	0.0328	0.188	CbGbCtD
Rabeprazole—ABCG2—Methotrexate—esophageal cancer	0.0288	0.165	CbGbCtD
Rabeprazole—ATP4A—gastric juice—esophageal cancer	0.0275	0.483	CbGeAlD
Rabeprazole—CYP2C9—Cisplatin—esophageal cancer	0.0165	0.0946	CbGbCtD
Rabeprazole—ATP4A—larynx—esophageal cancer	0.0122	0.215	CbGeAlD
Rabeprazole—ATP4B—digestive system—esophageal cancer	0.00385	0.0677	CbGeAlD
Rabeprazole—ATP4A—neck—esophageal cancer	0.00324	0.0569	CbGeAlD
Rabeprazole—ATP4A—epithelium—esophageal cancer	0.0022	0.0387	CbGeAlD
Rabeprazole—Esomeprazole—ATP4A—esophageal cancer	0.00185	0.277	CrCbGaD
Rabeprazole—ATP4A—digestive system—esophageal cancer	0.00168	0.0295	CbGeAlD
Rabeprazole—Pantoprazole—ATP4A—esophageal cancer	0.00133	0.201	CrCbGaD
Rabeprazole—Omeprazole—ATP4A—esophageal cancer	0.00109	0.164	CrCbGaD
Rabeprazole—Lansoprazole—ATP4A—esophageal cancer	0.000995	0.15	CrCbGaD
Rabeprazole—CYP1A1—epithelium—esophageal cancer	0.00062	0.0109	CbGeAlD
Rabeprazole—CYP1A1—bronchus—esophageal cancer	0.00061	0.0107	CbGeAlD
Rabeprazole—CYP2C19—digestive system—esophageal cancer	0.000585	0.0103	CbGeAlD
Rabeprazole—CYP1A1—trachea—esophageal cancer	0.000548	0.00964	CbGeAlD
Rabeprazole—Omeprazole—CYP1B1—esophageal cancer	0.000494	0.0742	CrCbGaD
Rabeprazole—CYP1A2—digestive system—esophageal cancer	0.000478	0.00841	CbGeAlD
Rabeprazole—CYP1A1—digestive system—esophageal cancer	0.000472	0.00829	CbGeAlD
Rabeprazole—CYP2C9—digestive system—esophageal cancer	0.000454	0.00798	CbGeAlD
Rabeprazole—Lansoprazole—CYP1B1—esophageal cancer	0.000452	0.0679	CrCbGaD
Rabeprazole—ABCG2—lung—esophageal cancer	0.000415	0.0073	CbGeAlD
Rabeprazole—CYP1A2—lung—esophageal cancer	0.000399	0.00702	CbGeAlD
Rabeprazole—CYP1A1—lung—esophageal cancer	0.000394	0.00693	CbGeAlD
Rabeprazole—CYP3A4—digestive system—esophageal cancer	0.000346	0.00609	CbGeAlD
Rabeprazole—CYP2D6—digestive system—esophageal cancer	0.000341	0.00599	CbGeAlD
Rabeprazole—ABCG2—lymph node—esophageal cancer	0.000284	0.00499	CbGeAlD
Rabeprazole—CYP1A1—lymph node—esophageal cancer	0.000269	0.00474	CbGeAlD
Rabeprazole—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000235	0.00282	CcSEcCtD
Rabeprazole—Arthritis—Capecitabine—esophageal cancer	0.000235	0.00282	CcSEcCtD
Rabeprazole—Vaginal inflammation—Methotrexate—esophageal cancer	0.000234	0.00281	CcSEcCtD
Rabeprazole—Pulmonary embolism—Methotrexate—esophageal cancer	0.000234	0.00281	CcSEcCtD
Rabeprazole—Myocardial infarction—Cisplatin—esophageal cancer	0.000234	0.00281	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000234	0.00281	CcSEcCtD
Rabeprazole—Stomatitis—Cisplatin—esophageal cancer	0.000232	0.00279	CcSEcCtD
Rabeprazole—Conjunctivitis—Cisplatin—esophageal cancer	0.000232	0.00278	CcSEcCtD
Rabeprazole—Hyponatraemia—Capecitabine—esophageal cancer	0.000229	0.00275	CcSEcCtD
Rabeprazole—Cystitis noninfective—Methotrexate—esophageal cancer	0.000228	0.00274	CcSEcCtD
Rabeprazole—Melaena—Methotrexate—esophageal cancer	0.000228	0.00274	CcSEcCtD
Rabeprazole—Osteoarthritis—Capecitabine—esophageal cancer	0.000228	0.00274	CcSEcCtD
Rabeprazole—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000228	0.00274	CcSEcCtD
Rabeprazole—Diplopia—Capecitabine—esophageal cancer	0.000228	0.00274	CcSEcCtD
Rabeprazole—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000226	0.00272	CcSEcCtD
Rabeprazole—Cystitis—Methotrexate—esophageal cancer	0.000226	0.00271	CcSEcCtD
Rabeprazole—Migraine—Capecitabine—esophageal cancer	0.000224	0.0027	CcSEcCtD
Rabeprazole—Vaginal infection—Methotrexate—esophageal cancer	0.000221	0.00265	CcSEcCtD
Rabeprazole—Face oedema—Capecitabine—esophageal cancer	0.00022	0.00265	CcSEcCtD
Rabeprazole—Bradycardia—Cisplatin—esophageal cancer	0.000218	0.00262	CcSEcCtD
Rabeprazole—Coma—Methotrexate—esophageal cancer	0.000214	0.00257	CcSEcCtD
Rabeprazole—Dehydration—Capecitabine—esophageal cancer	0.000212	0.00255	CcSEcCtD
Rabeprazole—Mouth ulceration—Methotrexate—esophageal cancer	0.000211	0.00254	CcSEcCtD
Rabeprazole—Bladder pain—Methotrexate—esophageal cancer	0.000211	0.00254	CcSEcCtD
Rabeprazole—Urine output increased—Methotrexate—esophageal cancer	0.000211	0.00254	CcSEcCtD
Rabeprazole—Neoplasm—Methotrexate—esophageal cancer	0.000211	0.00254	CcSEcCtD
Rabeprazole—Ecchymosis—Methotrexate—esophageal cancer	0.000211	0.00254	CcSEcCtD
Rabeprazole—Urinary tract disorder—Cisplatin—esophageal cancer	0.000211	0.00254	CcSEcCtD
Rabeprazole—Liver function test abnormal—Capecitabine—esophageal cancer	0.00021	0.00253	CcSEcCtD
Rabeprazole—Urethral disorder—Cisplatin—esophageal cancer	0.00021	0.00252	CcSEcCtD
Rabeprazole—Gynaecomastia—Methotrexate—esophageal cancer	0.000209	0.00251	CcSEcCtD
Rabeprazole—Dry skin—Capecitabine—esophageal cancer	0.000209	0.00251	CcSEcCtD
Rabeprazole—Abdominal pain upper—Capecitabine—esophageal cancer	0.000208	0.0025	CcSEcCtD
Rabeprazole—Hypokalaemia—Capecitabine—esophageal cancer	0.000207	0.00249	CcSEcCtD
Rabeprazole—Visual impairment—Cisplatin—esophageal cancer	0.000206	0.00248	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000205	0.00247	CcSEcCtD
Rabeprazole—Gastritis—Capecitabine—esophageal cancer	0.000202	0.00242	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000201	0.00242	CcSEcCtD
Rabeprazole—Eye disorder—Cisplatin—esophageal cancer	0.0002	0.0024	CcSEcCtD
Rabeprazole—Tinnitus—Cisplatin—esophageal cancer	0.000199	0.0024	CcSEcCtD
Rabeprazole—Lymphadenopathy—Methotrexate—esophageal cancer	0.000199	0.00239	CcSEcCtD
Rabeprazole—Abdominal distension—Capecitabine—esophageal cancer	0.000198	0.00238	CcSEcCtD
Rabeprazole—Dysphagia—Capecitabine—esophageal cancer	0.000197	0.00237	CcSEcCtD
Rabeprazole—Asthma—Capecitabine—esophageal cancer	0.000197	0.00237	CcSEcCtD
Rabeprazole—Thrombophlebitis—Methotrexate—esophageal cancer	0.000196	0.00236	CcSEcCtD
Rabeprazole—Diabetes mellitus—Methotrexate—esophageal cancer	0.000195	0.00234	CcSEcCtD
Rabeprazole—Photosensitivity—Methotrexate—esophageal cancer	0.000193	0.00232	CcSEcCtD
Rabeprazole—Polyuria—Methotrexate—esophageal cancer	0.000193	0.00232	CcSEcCtD
Rabeprazole—Angina pectoris—Capecitabine—esophageal cancer	0.000192	0.00231	CcSEcCtD
Rabeprazole—Arrhythmia—Cisplatin—esophageal cancer	0.000191	0.0023	CcSEcCtD
Rabeprazole—Bronchitis—Capecitabine—esophageal cancer	0.000189	0.00228	CcSEcCtD
Rabeprazole—Alopecia—Cisplatin—esophageal cancer	0.000189	0.00227	CcSEcCtD
Rabeprazole—Pancytopenia—Capecitabine—esophageal cancer	0.000187	0.00225	CcSEcCtD
Rabeprazole—Erythema—Cisplatin—esophageal cancer	0.000186	0.00224	CcSEcCtD
Rabeprazole—Malnutrition—Cisplatin—esophageal cancer	0.000186	0.00224	CcSEcCtD
Rabeprazole—Neutropenia—Capecitabine—esophageal cancer	0.000184	0.00221	CcSEcCtD
Rabeprazole—Dysuria—Capecitabine—esophageal cancer	0.000184	0.00221	CcSEcCtD
Rabeprazole—Flatulence—Cisplatin—esophageal cancer	0.000184	0.00221	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00018	0.00216	CcSEcCtD
Rabeprazole—Weight increased—Capecitabine—esophageal cancer	0.000179	0.00216	CcSEcCtD
Rabeprazole—Muscle spasms—Cisplatin—esophageal cancer	0.000179	0.00215	CcSEcCtD
Rabeprazole—Weight decreased—Capecitabine—esophageal cancer	0.000178	0.00214	CcSEcCtD
Rabeprazole—Hyperglycaemia—Capecitabine—esophageal cancer	0.000178	0.00214	CcSEcCtD
Rabeprazole—Pneumonia—Capecitabine—esophageal cancer	0.000177	0.00212	CcSEcCtD
Rabeprazole—Vision blurred—Cisplatin—esophageal cancer	0.000176	0.00211	CcSEcCtD
Rabeprazole—Tremor—Cisplatin—esophageal cancer	0.000174	0.0021	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000174	0.00209	CcSEcCtD
Rabeprazole—Pantoprazole—ABCB1—esophageal cancer	0.000174	0.0261	CrCbGaD
Rabeprazole—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000173	0.00208	CcSEcCtD
Rabeprazole—Ill-defined disorder—Cisplatin—esophageal cancer	0.000173	0.00208	CcSEcCtD
Rabeprazole—Myocardial infarction—Capecitabine—esophageal cancer	0.000172	0.00207	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000172	0.00207	CcSEcCtD
Rabeprazole—Anaemia—Cisplatin—esophageal cancer	0.000172	0.00207	CcSEcCtD
Rabeprazole—Jaundice—Capecitabine—esophageal cancer	0.000171	0.00206	CcSEcCtD
Rabeprazole—Stomatitis—Capecitabine—esophageal cancer	0.000171	0.00206	CcSEcCtD
Rabeprazole—Conjunctivitis—Capecitabine—esophageal cancer	0.000171	0.00205	CcSEcCtD
Rabeprazole—Urinary tract infection—Capecitabine—esophageal cancer	0.000171	0.00205	CcSEcCtD
Rabeprazole—Osteoarthritis—Methotrexate—esophageal cancer	0.00017	0.00204	CcSEcCtD
Rabeprazole—Malaise—Cisplatin—esophageal cancer	0.000168	0.00202	CcSEcCtD
Rabeprazole—Haematuria—Capecitabine—esophageal cancer	0.000167	0.00201	CcSEcCtD
Rabeprazole—Leukopenia—Cisplatin—esophageal cancer	0.000167	0.002	CcSEcCtD
Rabeprazole—Epistaxis—Capecitabine—esophageal cancer	0.000166	0.00199	CcSEcCtD
Rabeprazole—Agranulocytosis—Capecitabine—esophageal cancer	0.000164	0.00197	CcSEcCtD
Rabeprazole—Convulsion—Cisplatin—esophageal cancer	0.000161	0.00194	CcSEcCtD
Rabeprazole—Bradycardia—Capecitabine—esophageal cancer	0.000161	0.00193	CcSEcCtD
Rabeprazole—Myalgia—Cisplatin—esophageal cancer	0.000159	0.00191	CcSEcCtD
Rabeprazole—Rhinitis—Capecitabine—esophageal cancer	0.000158	0.0019	CcSEcCtD
Rabeprazole—Anxiety—Cisplatin—esophageal cancer	0.000158	0.0019	CcSEcCtD
Rabeprazole—Hepatitis—Capecitabine—esophageal cancer	0.000158	0.0019	CcSEcCtD
Rabeprazole—Liver function test abnormal—Methotrexate—esophageal cancer	0.000157	0.00188	CcSEcCtD
Rabeprazole—Discomfort—Cisplatin—esophageal cancer	0.000157	0.00188	CcSEcCtD
Rabeprazole—Pharyngitis—Capecitabine—esophageal cancer	0.000157	0.00188	CcSEcCtD
Rabeprazole—Urinary tract disorder—Capecitabine—esophageal cancer	0.000156	0.00187	CcSEcCtD
Rabeprazole—Oedema peripheral—Capecitabine—esophageal cancer	0.000155	0.00187	CcSEcCtD
Rabeprazole—Urethral disorder—Capecitabine—esophageal cancer	0.000155	0.00186	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000153	0.00184	CcSEcCtD
Rabeprazole—Anaphylactic shock—Cisplatin—esophageal cancer	0.000152	0.00183	CcSEcCtD
Rabeprazole—Oedema—Cisplatin—esophageal cancer	0.000152	0.00183	CcSEcCtD
Rabeprazole—Visual impairment—Capecitabine—esophageal cancer	0.000152	0.00183	CcSEcCtD
Rabeprazole—Erythema multiforme—Capecitabine—esophageal cancer	0.000149	0.00179	CcSEcCtD
Rabeprazole—Thrombocytopenia—Cisplatin—esophageal cancer	0.000149	0.00179	CcSEcCtD
Rabeprazole—Tachycardia—Cisplatin—esophageal cancer	0.000148	0.00178	CcSEcCtD
Rabeprazole—Eye disorder—Capecitabine—esophageal cancer	0.000147	0.00177	CcSEcCtD
Rabeprazole—Tinnitus—Capecitabine—esophageal cancer	0.000147	0.00177	CcSEcCtD
Rabeprazole—Hyperhidrosis—Cisplatin—esophageal cancer	0.000147	0.00177	CcSEcCtD
Rabeprazole—Asthma—Methotrexate—esophageal cancer	0.000147	0.00176	CcSEcCtD
Rabeprazole—Anorexia—Cisplatin—esophageal cancer	0.000145	0.00174	CcSEcCtD
Rabeprazole—Pancreatitis—Methotrexate—esophageal cancer	0.000144	0.00173	CcSEcCtD
Rabeprazole—Angiopathy—Capecitabine—esophageal cancer	0.000143	0.00172	CcSEcCtD
Rabeprazole—Hypotension—Cisplatin—esophageal cancer	0.000142	0.00171	CcSEcCtD
Rabeprazole—Omeprazole—ABCB1—esophageal cancer	0.000142	0.0213	CrCbGaD
Rabeprazole—Chills—Capecitabine—esophageal cancer	0.000142	0.0017	CcSEcCtD
Rabeprazole—Arrhythmia—Capecitabine—esophageal cancer	0.000141	0.00169	CcSEcCtD
Rabeprazole—Alopecia—Capecitabine—esophageal cancer	0.000139	0.00167	CcSEcCtD
Rabeprazole—Pancytopenia—Methotrexate—esophageal cancer	0.000139	0.00167	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000138	0.00166	CcSEcCtD
Rabeprazole—Erythema—Capecitabine—esophageal cancer	0.000137	0.00165	CcSEcCtD
Rabeprazole—Malnutrition—Capecitabine—esophageal cancer	0.000137	0.00165	CcSEcCtD
Rabeprazole—Dysuria—Methotrexate—esophageal cancer	0.000137	0.00165	CcSEcCtD
Rabeprazole—Neutropenia—Methotrexate—esophageal cancer	0.000137	0.00165	CcSEcCtD
Rabeprazole—Paraesthesia—Cisplatin—esophageal cancer	0.000136	0.00164	CcSEcCtD
Rabeprazole—Dyspnoea—Cisplatin—esophageal cancer	0.000136	0.00163	CcSEcCtD
Rabeprazole—Flatulence—Capecitabine—esophageal cancer	0.000135	0.00163	CcSEcCtD
Rabeprazole—Erectile dysfunction—Methotrexate—esophageal cancer	0.000135	0.00162	CcSEcCtD
Rabeprazole—Dysgeusia—Capecitabine—esophageal cancer	0.000134	0.00162	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000134	0.00161	CcSEcCtD
Rabeprazole—Back pain—Capecitabine—esophageal cancer	0.000133	0.0016	CcSEcCtD
Rabeprazole—Decreased appetite—Cisplatin—esophageal cancer	0.000132	0.00159	CcSEcCtD
Rabeprazole—Muscle spasms—Capecitabine—esophageal cancer	0.000132	0.00159	CcSEcCtD
Rabeprazole—Pneumonia—Methotrexate—esophageal cancer	0.000132	0.00158	CcSEcCtD
Rabeprazole—Pain—Cisplatin—esophageal cancer	0.00013	0.00156	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00013	0.00156	CcSEcCtD
Rabeprazole—Lansoprazole—ABCB1—esophageal cancer	0.00013	0.0195	CrCbGaD
Rabeprazole—Vision blurred—Capecitabine—esophageal cancer	0.000129	0.00156	CcSEcCtD
Rabeprazole—Tremor—Capecitabine—esophageal cancer	0.000129	0.00155	CcSEcCtD
Rabeprazole—Stomatitis—Methotrexate—esophageal cancer	0.000127	0.00153	CcSEcCtD
Rabeprazole—Ill-defined disorder—Capecitabine—esophageal cancer	0.000127	0.00153	CcSEcCtD
Rabeprazole—Conjunctivitis—Methotrexate—esophageal cancer	0.000127	0.00153	CcSEcCtD
Rabeprazole—Anaemia—Capecitabine—esophageal cancer	0.000127	0.00153	CcSEcCtD
Rabeprazole—Sweating—Methotrexate—esophageal cancer	0.000125	0.00151	CcSEcCtD
Rabeprazole—Feeling abnormal—Cisplatin—esophageal cancer	0.000125	0.00151	CcSEcCtD
Rabeprazole—Haematuria—Methotrexate—esophageal cancer	0.000125	0.0015	CcSEcCtD
Rabeprazole—Malaise—Capecitabine—esophageal cancer	0.000124	0.00149	CcSEcCtD
Rabeprazole—Epistaxis—Methotrexate—esophageal cancer	0.000123	0.00148	CcSEcCtD
Rabeprazole—Vertigo—Capecitabine—esophageal cancer	0.000123	0.00148	CcSEcCtD
Rabeprazole—Syncope—Capecitabine—esophageal cancer	0.000123	0.00148	CcSEcCtD
Rabeprazole—Leukopenia—Capecitabine—esophageal cancer	0.000123	0.00148	CcSEcCtD
Rabeprazole—Agranulocytosis—Methotrexate—esophageal cancer	0.000122	0.00147	CcSEcCtD
Rabeprazole—Palpitations—Capecitabine—esophageal cancer	0.000121	0.00146	CcSEcCtD
Rabeprazole—Loss of consciousness—Capecitabine—esophageal cancer	0.000121	0.00145	CcSEcCtD
Rabeprazole—Body temperature increased—Cisplatin—esophageal cancer	0.00012	0.00144	CcSEcCtD
Rabeprazole—Cough—Capecitabine—esophageal cancer	0.00012	0.00144	CcSEcCtD
Rabeprazole—Hypertension—Capecitabine—esophageal cancer	0.000119	0.00142	CcSEcCtD
Rabeprazole—Hepatitis—Methotrexate—esophageal cancer	0.000117	0.00141	CcSEcCtD
Rabeprazole—Arthralgia—Capecitabine—esophageal cancer	0.000117	0.0014	CcSEcCtD
Rabeprazole—Myalgia—Capecitabine—esophageal cancer	0.000117	0.0014	CcSEcCtD
Rabeprazole—Chest pain—Capecitabine—esophageal cancer	0.000117	0.0014	CcSEcCtD
Rabeprazole—Pharyngitis—Methotrexate—esophageal cancer	0.000117	0.0014	CcSEcCtD
Rabeprazole—Anxiety—Capecitabine—esophageal cancer	0.000116	0.0014	CcSEcCtD
Rabeprazole—Urinary tract disorder—Methotrexate—esophageal cancer	0.000116	0.00139	CcSEcCtD
Rabeprazole—Discomfort—Capecitabine—esophageal cancer	0.000115	0.00139	CcSEcCtD
Rabeprazole—Urethral disorder—Methotrexate—esophageal cancer	0.000115	0.00138	CcSEcCtD
Rabeprazole—Dry mouth—Capecitabine—esophageal cancer	0.000114	0.00137	CcSEcCtD
Rabeprazole—Visual impairment—Methotrexate—esophageal cancer	0.000113	0.00136	CcSEcCtD
Rabeprazole—Confusional state—Capecitabine—esophageal cancer	0.000113	0.00136	CcSEcCtD
Rabeprazole—Oedema—Capecitabine—esophageal cancer	0.000112	0.00135	CcSEcCtD
Rabeprazole—Hypersensitivity—Cisplatin—esophageal cancer	0.000112	0.00135	CcSEcCtD
Rabeprazole—Erythema multiforme—Methotrexate—esophageal cancer	0.000111	0.00133	CcSEcCtD
Rabeprazole—Shock—Capecitabine—esophageal cancer	0.00011	0.00132	CcSEcCtD
Rabeprazole—Eye disorder—Methotrexate—esophageal cancer	0.00011	0.00132	CcSEcCtD
Rabeprazole—Thrombocytopenia—Capecitabine—esophageal cancer	0.00011	0.00132	CcSEcCtD
Rabeprazole—Tinnitus—Methotrexate—esophageal cancer	0.000109	0.00132	CcSEcCtD
Rabeprazole—Tachycardia—Capecitabine—esophageal cancer	0.000109	0.00131	CcSEcCtD
Rabeprazole—Asthenia—Cisplatin—esophageal cancer	0.000109	0.00131	CcSEcCtD
Rabeprazole—Hyperhidrosis—Capecitabine—esophageal cancer	0.000108	0.0013	CcSEcCtD
Rabeprazole—Anorexia—Capecitabine—esophageal cancer	0.000107	0.00128	CcSEcCtD
Rabeprazole—Angiopathy—Methotrexate—esophageal cancer	0.000107	0.00128	CcSEcCtD
Rabeprazole—Chills—Methotrexate—esophageal cancer	0.000105	0.00127	CcSEcCtD
Rabeprazole—Hypotension—Capecitabine—esophageal cancer	0.000105	0.00126	CcSEcCtD
Rabeprazole—Diarrhoea—Cisplatin—esophageal cancer	0.000104	0.00125	CcSEcCtD
Rabeprazole—Alopecia—Methotrexate—esophageal cancer	0.000104	0.00125	CcSEcCtD
Rabeprazole—Malnutrition—Methotrexate—esophageal cancer	0.000102	0.00123	CcSEcCtD
Rabeprazole—Erythema—Methotrexate—esophageal cancer	0.000102	0.00123	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000102	0.00123	CcSEcCtD
Rabeprazole—Insomnia—Capecitabine—esophageal cancer	0.000101	0.00122	CcSEcCtD
Rabeprazole—Paraesthesia—Capecitabine—esophageal cancer	0.000101	0.00121	CcSEcCtD
Rabeprazole—Dysgeusia—Methotrexate—esophageal cancer	0.0001	0.0012	CcSEcCtD
Rabeprazole—Dyspnoea—Capecitabine—esophageal cancer	9.99e-05	0.0012	CcSEcCtD
Rabeprazole—Back pain—Methotrexate—esophageal cancer	9.89e-05	0.00119	CcSEcCtD
Rabeprazole—Dyspepsia—Capecitabine—esophageal cancer	9.86e-05	0.00119	CcSEcCtD
Rabeprazole—Decreased appetite—Capecitabine—esophageal cancer	9.74e-05	0.00117	CcSEcCtD
Rabeprazole—Vomiting—Cisplatin—esophageal cancer	9.66e-05	0.00116	CcSEcCtD
Rabeprazole—Vision blurred—Methotrexate—esophageal cancer	9.63e-05	0.00116	CcSEcCtD
Rabeprazole—Rash—Cisplatin—esophageal cancer	9.58e-05	0.00115	CcSEcCtD
Rabeprazole—Pain—Capecitabine—esophageal cancer	9.58e-05	0.00115	CcSEcCtD
Rabeprazole—Constipation—Capecitabine—esophageal cancer	9.58e-05	0.00115	CcSEcCtD
Rabeprazole—Dermatitis—Cisplatin—esophageal cancer	9.57e-05	0.00115	CcSEcCtD
Rabeprazole—Ill-defined disorder—Methotrexate—esophageal cancer	9.48e-05	0.00114	CcSEcCtD
Rabeprazole—Anaemia—Methotrexate—esophageal cancer	9.45e-05	0.00114	CcSEcCtD
Rabeprazole—Feeling abnormal—Capecitabine—esophageal cancer	9.23e-05	0.00111	CcSEcCtD
Rabeprazole—Malaise—Methotrexate—esophageal cancer	9.22e-05	0.00111	CcSEcCtD
Rabeprazole—Vertigo—Methotrexate—esophageal cancer	9.18e-05	0.0011	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Capecitabine—esophageal cancer	9.16e-05	0.0011	CcSEcCtD
Rabeprazole—Leukopenia—Methotrexate—esophageal cancer	9.15e-05	0.0011	CcSEcCtD
Rabeprazole—Nausea—Cisplatin—esophageal cancer	9.03e-05	0.00109	CcSEcCtD
Rabeprazole—Cough—Methotrexate—esophageal cancer	8.92e-05	0.00107	CcSEcCtD
Rabeprazole—Urticaria—Capecitabine—esophageal cancer	8.9e-05	0.00107	CcSEcCtD
Rabeprazole—Abdominal pain—Capecitabine—esophageal cancer	8.86e-05	0.00106	CcSEcCtD
Rabeprazole—Body temperature increased—Capecitabine—esophageal cancer	8.86e-05	0.00106	CcSEcCtD
Rabeprazole—Convulsion—Methotrexate—esophageal cancer	8.85e-05	0.00106	CcSEcCtD
Rabeprazole—Myalgia—Methotrexate—esophageal cancer	8.7e-05	0.00105	CcSEcCtD
Rabeprazole—Chest pain—Methotrexate—esophageal cancer	8.7e-05	0.00105	CcSEcCtD
Rabeprazole—Arthralgia—Methotrexate—esophageal cancer	8.7e-05	0.00105	CcSEcCtD
Rabeprazole—Discomfort—Methotrexate—esophageal cancer	8.6e-05	0.00103	CcSEcCtD
Rabeprazole—Confusional state—Methotrexate—esophageal cancer	8.41e-05	0.00101	CcSEcCtD
Rabeprazole—Anaphylactic shock—Methotrexate—esophageal cancer	8.34e-05	0.001	CcSEcCtD
Rabeprazole—Hypersensitivity—Capecitabine—esophageal cancer	8.25e-05	0.000992	CcSEcCtD
Rabeprazole—Thrombocytopenia—Methotrexate—esophageal cancer	8.17e-05	0.000982	CcSEcCtD
Rabeprazole—Hyperhidrosis—Methotrexate—esophageal cancer	8.06e-05	0.000969	CcSEcCtD
Rabeprazole—Asthenia—Capecitabine—esophageal cancer	8.04e-05	0.000966	CcSEcCtD
Rabeprazole—Anorexia—Methotrexate—esophageal cancer	7.95e-05	0.000956	CcSEcCtD
Rabeprazole—Pruritus—Capecitabine—esophageal cancer	7.93e-05	0.000953	CcSEcCtD
Rabeprazole—Hypotension—Methotrexate—esophageal cancer	7.79e-05	0.000937	CcSEcCtD
Rabeprazole—Diarrhoea—Capecitabine—esophageal cancer	7.67e-05	0.000921	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Methotrexate—esophageal cancer	7.6e-05	0.000913	CcSEcCtD
Rabeprazole—Insomnia—Methotrexate—esophageal cancer	7.54e-05	0.000907	CcSEcCtD
Rabeprazole—Paraesthesia—Methotrexate—esophageal cancer	7.49e-05	0.0009	CcSEcCtD
Rabeprazole—Dyspnoea—Methotrexate—esophageal cancer	7.44e-05	0.000894	CcSEcCtD
Rabeprazole—Somnolence—Methotrexate—esophageal cancer	7.41e-05	0.000891	CcSEcCtD
Rabeprazole—Dizziness—Capecitabine—esophageal cancer	7.41e-05	0.00089	CcSEcCtD
Rabeprazole—Dyspepsia—Methotrexate—esophageal cancer	7.34e-05	0.000882	CcSEcCtD
Rabeprazole—Decreased appetite—Methotrexate—esophageal cancer	7.25e-05	0.000871	CcSEcCtD
Rabeprazole—Pain—Methotrexate—esophageal cancer	7.13e-05	0.000857	CcSEcCtD
Rabeprazole—Vomiting—Capecitabine—esophageal cancer	7.12e-05	0.000856	CcSEcCtD
Rabeprazole—Rash—Capecitabine—esophageal cancer	7.06e-05	0.000849	CcSEcCtD
Rabeprazole—Dermatitis—Capecitabine—esophageal cancer	7.06e-05	0.000848	CcSEcCtD
Rabeprazole—Headache—Capecitabine—esophageal cancer	7.02e-05	0.000844	CcSEcCtD
Rabeprazole—Feeling abnormal—Methotrexate—esophageal cancer	6.87e-05	0.000826	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Methotrexate—esophageal cancer	6.82e-05	0.00082	CcSEcCtD
Rabeprazole—Nausea—Capecitabine—esophageal cancer	6.66e-05	0.0008	CcSEcCtD
Rabeprazole—Urticaria—Methotrexate—esophageal cancer	6.63e-05	0.000796	CcSEcCtD
Rabeprazole—Abdominal pain—Methotrexate—esophageal cancer	6.59e-05	0.000792	CcSEcCtD
Rabeprazole—Body temperature increased—Methotrexate—esophageal cancer	6.59e-05	0.000792	CcSEcCtD
Rabeprazole—Hypersensitivity—Methotrexate—esophageal cancer	6.15e-05	0.000739	CcSEcCtD
Rabeprazole—Asthenia—Methotrexate—esophageal cancer	5.98e-05	0.000719	CcSEcCtD
Rabeprazole—Pruritus—Methotrexate—esophageal cancer	5.9e-05	0.000709	CcSEcCtD
Rabeprazole—Diarrhoea—Methotrexate—esophageal cancer	5.71e-05	0.000686	CcSEcCtD
Rabeprazole—Dizziness—Methotrexate—esophageal cancer	5.52e-05	0.000663	CcSEcCtD
Rabeprazole—Vomiting—Methotrexate—esophageal cancer	5.3e-05	0.000637	CcSEcCtD
Rabeprazole—Rash—Methotrexate—esophageal cancer	5.26e-05	0.000632	CcSEcCtD
Rabeprazole—Dermatitis—Methotrexate—esophageal cancer	5.25e-05	0.000631	CcSEcCtD
Rabeprazole—Headache—Methotrexate—esophageal cancer	5.23e-05	0.000628	CcSEcCtD
Rabeprazole—Nausea—Methotrexate—esophageal cancer	4.95e-05	0.000595	CcSEcCtD
Rabeprazole—CYP1A1—Metabolism—SLC10A2—esophageal cancer	2.24e-05	0.000303	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALOX15—esophageal cancer	2.23e-05	0.000302	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.21e-05	0.000299	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	2.16e-05	0.000293	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—BLVRB—esophageal cancer	2.15e-05	0.000291	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC52A3—esophageal cancer	2.15e-05	0.000291	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTO1—esophageal cancer	2.13e-05	0.000288	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—TPI1—esophageal cancer	2.13e-05	0.000288	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CA2—esophageal cancer	2.05e-05	0.000277	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALDOB—esophageal cancer	2.04e-05	0.000276	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2e-05	0.000271	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC52A3—esophageal cancer	1.98e-05	0.000268	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—BLVRB—esophageal cancer	1.98e-05	0.000268	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GAPDH—esophageal cancer	1.97e-05	0.000266	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—BLVRB—esophageal cancer	1.96e-05	0.000266	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC52A3—esophageal cancer	1.96e-05	0.000266	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CRABP1—esophageal cancer	1.95e-05	0.000264	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.93e-05	0.00026	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PLCE1—esophageal cancer	1.9e-05	0.000257	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ADH7—esophageal cancer	1.9e-05	0.000257	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	1.89e-05	0.000255	CbGpPWpGaD
Rabeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	1.88e-05	0.000255	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.88e-05	0.000254	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GNG7—esophageal cancer	1.85e-05	0.000251	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CA1—esophageal cancer	1.83e-05	0.000248	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC10A2—esophageal cancer	1.83e-05	0.000248	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.76e-05	0.000237	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALDH2—esophageal cancer	1.74e-05	0.000235	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CA1—esophageal cancer	1.68e-05	0.000228	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC10A2—esophageal cancer	1.68e-05	0.000228	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—BLVRB—esophageal cancer	1.68e-05	0.000227	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC52A3—esophageal cancer	1.68e-05	0.000227	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CA2—esophageal cancer	1.68e-05	0.000227	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC10A2—esophageal cancer	1.67e-05	0.000226	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CA1—esophageal cancer	1.67e-05	0.000226	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ADH1B—esophageal cancer	1.67e-05	0.000226	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTT1—esophageal cancer	1.65e-05	0.000223	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.64e-05	0.000221	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP2A6—esophageal cancer	1.63e-05	0.000221	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—TYMP—esophageal cancer	1.6e-05	0.000216	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PLCE1—esophageal cancer	1.56e-05	0.000211	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ADH7—esophageal cancer	1.56e-05	0.000211	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP26A1—esophageal cancer	1.55e-05	0.00021	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ENO1—esophageal cancer	1.55e-05	0.000209	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS1—esophageal cancer	1.55e-05	0.000209	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.55e-05	0.000209	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CA2—esophageal cancer	1.54e-05	0.000208	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.54e-05	0.000208	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CA2—esophageal cancer	1.53e-05	0.000207	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PSME1—esophageal cancer	1.53e-05	0.000206	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PSME2—esophageal cancer	1.53e-05	0.000206	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALOX15—esophageal cancer	1.51e-05	0.000204	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.5e-05	0.000203	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.49e-05	0.000202	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—TPI1—esophageal cancer	1.44e-05	0.000195	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTO1—esophageal cancer	1.44e-05	0.000195	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ADH7—esophageal cancer	1.43e-05	0.000194	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PLCE1—esophageal cancer	1.43e-05	0.000194	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC10A2—esophageal cancer	1.43e-05	0.000193	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CA1—esophageal cancer	1.43e-05	0.000193	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ADH7—esophageal cancer	1.42e-05	0.000192	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.42e-05	0.000192	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.4e-05	0.00019	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALDOB—esophageal cancer	1.38e-05	0.000187	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ADH1B—esophageal cancer	1.37e-05	0.000185	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GAPDH—esophageal cancer	1.33e-05	0.00018	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CRABP1—esophageal cancer	1.32e-05	0.000178	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP1B1—esophageal cancer	1.32e-05	0.000178	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CA2—esophageal cancer	1.31e-05	0.000177	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TYMP—esophageal cancer	1.31e-05	0.000176	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.3e-05	0.000175	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.3e-05	0.000175	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.28e-05	0.000173	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.27e-05	0.000172	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ADH1B—esophageal cancer	1.26e-05	0.00017	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GNG7—esophageal cancer	1.25e-05	0.00017	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.25e-05	0.000168	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP19A1—esophageal cancer	1.24e-05	0.000167	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.24e-05	0.000167	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ADH7—esophageal cancer	1.21e-05	0.000164	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.21e-05	0.000164	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TYMP—esophageal cancer	1.2e-05	0.000162	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.2e-05	0.000162	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TYMP—esophageal cancer	1.19e-05	0.000161	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TPI1—esophageal cancer	1.18e-05	0.00016	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.18e-05	0.00016	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALDH2—esophageal cancer	1.18e-05	0.000159	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP26A1—esophageal cancer	1.17e-05	0.000158	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.16e-05	0.000157	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.14e-05	0.000154	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.13e-05	0.000153	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—HMOX1—esophageal cancer	1.13e-05	0.000153	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.13e-05	0.000153	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTT1—esophageal cancer	1.12e-05	0.000151	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP2A6—esophageal cancer	1.11e-05	0.000149	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CA1—esophageal cancer	1.1e-05	0.000149	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.1e-05	0.000149	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.1e-05	0.000149	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.09e-05	0.000147	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.09e-05	0.000147	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TPI1—esophageal cancer	1.09e-05	0.000147	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ABCB1—esophageal cancer	1.08e-05	0.000147	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.08e-05	0.000146	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TPI1—esophageal cancer	1.08e-05	0.000146	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.08e-05	0.000146	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.06e-05	0.000144	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS1—esophageal cancer	1.05e-05	0.000142	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ENO1—esophageal cancer	1.05e-05	0.000142	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALDOB—esophageal cancer	1.04e-05	0.000141	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PSME1—esophageal cancer	1.03e-05	0.00014	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PSME2—esophageal cancer	1.03e-05	0.00014	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.03e-05	0.00014	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GNG7—esophageal cancer	1.03e-05	0.000139	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TYMP—esophageal cancer	1.02e-05	0.000138	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CA2—esophageal cancer	1.01e-05	0.000136	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GAPDH—esophageal cancer	1e-05	0.000135	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GAPDH—esophageal cancer	9.93e-06	0.000134	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CRABP1—esophageal cancer	9.93e-06	0.000134	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP26A1—esophageal cancer	9.89e-06	0.000134	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CRABP1—esophageal cancer	9.84e-06	0.000133	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALOX15—esophageal cancer	9.64e-06	0.00013	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALDH2—esophageal cancer	9.62e-06	0.00013	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GNG7—esophageal cancer	9.45e-06	0.000128	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ADH7—esophageal cancer	9.37e-06	0.000127	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.37e-06	0.000127	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GNG7—esophageal cancer	9.36e-06	0.000127	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTO1—esophageal cancer	9.2e-06	0.000124	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TPI1—esophageal cancer	9.2e-06	0.000124	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTT1—esophageal cancer	9.15e-06	0.000124	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP2A6—esophageal cancer	9.05e-06	0.000122	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.02e-06	0.000122	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.01e-06	0.000122	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP1B1—esophageal cancer	8.91e-06	0.000121	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALDH2—esophageal cancer	8.85e-06	0.00012	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALDOB—esophageal cancer	8.82e-06	0.000119	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALDH2—esophageal cancer	8.77e-06	0.000119	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ENO1—esophageal cancer	8.58e-06	0.000116	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS1—esophageal cancer	8.58e-06	0.000116	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GAPDH—esophageal cancer	8.49e-06	0.000115	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PSME2—esophageal cancer	8.45e-06	0.000114	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PSME1—esophageal cancer	8.45e-06	0.000114	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTT1—esophageal cancer	8.42e-06	0.000114	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CRABP1—esophageal cancer	8.41e-06	0.000114	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP19A1—esophageal cancer	8.38e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTT1—esophageal cancer	8.35e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP2A6—esophageal cancer	8.32e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP2A6—esophageal cancer	8.25e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.22e-06	0.000111	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.21e-06	0.000111	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GNG7—esophageal cancer	8e-06	0.000108	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ENO1—esophageal cancer	7.89e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS1—esophageal cancer	7.89e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TYMP—esophageal cancer	7.85e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ENO1—esophageal cancer	7.82e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS1—esophageal cancer	7.82e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PSME1—esophageal cancer	7.77e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PSME2—esophageal cancer	7.77e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PSME1—esophageal cancer	7.71e-06	0.000104	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PSME2—esophageal cancer	7.71e-06	0.000104	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—HMOX1—esophageal cancer	7.65e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.64e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.5e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALDH2—esophageal cancer	7.5e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.44e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.38e-06	9.98e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ABCB1—esophageal cancer	7.34e-06	9.92e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1B1—esophageal cancer	7.29e-06	9.86e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CREBBP—esophageal cancer	7.25e-06	9.8e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTT1—esophageal cancer	7.13e-06	9.64e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TPI1—esophageal cancer	7.1e-06	9.6e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.1e-06	9.6e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2A6—esophageal cancer	7.05e-06	9.53e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.02e-06	9.5e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP19A1—esophageal cancer	6.86e-06	9.27e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.81e-06	9.2e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.73e-06	9.1e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1B1—esophageal cancer	6.71e-06	9.07e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS1—esophageal cancer	6.68e-06	9.04e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ENO1—esophageal cancer	6.68e-06	9.04e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1B1—esophageal cancer	6.65e-06	8.99e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PSME2—esophageal cancer	6.59e-06	8.9e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PSME1—esophageal cancer	6.59e-06	8.9e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.55e-06	8.86e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.49e-06	8.78e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—NOS3—esophageal cancer	6.49e-06	8.77e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP19A1—esophageal cancer	6.31e-06	8.53e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HMOX1—esophageal cancer	6.26e-06	8.46e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP19A1—esophageal cancer	6.25e-06	8.45e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GNG7—esophageal cancer	6.18e-06	8.35e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.14e-06	8.3e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCB1—esophageal cancer	6.01e-06	8.12e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—esophageal cancer	5.93e-06	8.02e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.79e-06	7.82e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HMOX1—esophageal cancer	5.76e-06	7.78e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.75e-06	7.78e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.71e-06	7.71e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP1B1—esophageal cancer	5.68e-06	7.68e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.6e-06	7.57e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.55e-06	7.5e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCB1—esophageal cancer	5.52e-06	7.47e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.5e-06	7.44e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.48e-06	7.4e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.44e-06	7.36e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP19A1—esophageal cancer	5.34e-06	7.22e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ENO1—esophageal cancer	5.16e-06	6.97e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.16e-06	6.97e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PSME1—esophageal cancer	5.08e-06	6.87e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PSME2—esophageal cancer	5.08e-06	6.87e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—EP300—esophageal cancer	4.94e-06	6.67e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CREBBP—esophageal cancer	4.91e-06	6.63e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HMOX1—esophageal cancer	4.88e-06	6.59e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.78e-06	6.47e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCB1—esophageal cancer	4.68e-06	6.33e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.54e-06	6.14e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NOS3—esophageal cancer	4.39e-06	5.94e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.39e-06	5.93e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.14e-06	5.6e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.12e-06	5.58e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—esophageal cancer	4.02e-06	5.43e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CREBBP—esophageal cancer	4.01e-06	5.43e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.76e-06	5.09e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.69e-06	4.99e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.66e-06	4.95e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CA—esophageal cancer	3.65e-06	4.94e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.61e-06	4.88e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NOS3—esophageal cancer	3.59e-06	4.86e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.54e-06	4.78e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—EP300—esophageal cancer	3.34e-06	4.52e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NOS3—esophageal cancer	3.31e-06	4.47e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—esophageal cancer	3.29e-06	4.44e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NOS3—esophageal cancer	3.28e-06	4.43e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CREBBP—esophageal cancer	3.13e-06	4.23e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—esophageal cancer	3.02e-06	4.09e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—esophageal cancer	3e-06	4.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NOS3—esophageal cancer	2.8e-06	3.79e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—EP300—esophageal cancer	2.73e-06	3.7e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—esophageal cancer	2.56e-06	3.46e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—EP300—esophageal cancer	2.51e-06	3.4e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—EP300—esophageal cancer	2.49e-06	3.37e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CA—esophageal cancer	2.47e-06	3.34e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.41e-06	3.26e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NOS3—esophageal cancer	2.16e-06	2.92e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—EP300—esophageal cancer	2.13e-06	2.88e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CA—esophageal cancer	2.02e-06	2.73e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.98e-06	2.67e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.86e-06	2.51e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.84e-06	2.49e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—EP300—esophageal cancer	1.64e-06	2.22e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.58e-06	2.13e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.22e-06	1.64e-05	CbGpPWpGaD
